Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

Compare

1.240

+0.070 (5.98%)

At close: Feb 11, 2026, 4:00 PM EST

1.220

0.00 (0.00%)

Pre-market: Feb 12, 2026, 4:22 AM EST

Cyclerion Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	4.57	3.23	7.57	13.38	53.96	54.4
Cash & Short-Term Investments	4.57	3.23	7.57	13.38	53.96	54.4
Cash Growth	59.05%	-57.31%	-43.42%	-75.20%	-0.80%	-42.68%
Receivables	0.1	0.56	-	0.1	0.1	0.13
Prepaid Expenses	0.39	0.42	0.44	0.81	0.93	2.42
Other Current Assets	0.01	0.02	0.01	0.54	0.47	1.56
Total Current Assets	5.07	4.23	8.02	14.82	55.46	58.5
Property, Plant & Equipment	-	-	-	1.22	1.47	50.27
Long-Term Investments	5.35	5.35	5.35	-	-	-
Other Long-Term Assets	-	-	-	2.04	2.41	6.61
Total Assets	10.42	9.58	13.37	18.08	59.33	115.38
Accounts Payable	0.48	0.39	1.2	2.97	1.83	1.15
Accrued Expenses	0.3	0.27	0.78	4.59	8.73	8.83
Short-Term Debt	-	-	-	-	-	3.51
Current Portion of Leases	-	-	-	-	-	3.29
Other Current Liabilities	0.1	0.06	0.11	0.07	0.53	0.18
Total Current Liabilities	0.88	0.73	2.09	7.63	11.09	16.95
Long-Term Leases	-	-	-	-	-	38.93
Total Liabilities	0.88	0.73	2.09	7.63	11.09	55.89
Additional Paid-In Capital	279.76	276.34	275.72	269.63	263.35	222.95
Retained Earnings	-270.22	-267.49	-264.42	-259.15	-215.08	-163.43
Comprehensive Income & Other	-	-	-0.01	-0.02	-0.02	-0.03
Shareholders' Equity	9.54	8.85	11.29	10.45	48.25	59.49
Total Liabilities & Equity	10.42	9.58	13.37	18.08	59.33	115.38
Total Debt	-	-	-	-	-	45.74
Net Cash (Debt)	4.57	3.23	7.57	13.38	53.96	8.66
Net Cash Growth	59.05%	-57.31%	-43.42%	-75.20%	523.11%	-58.71%
Net Cash Per Share	1.60	1.28	3.24	6.16	27.57	5.70
Filing Date Shares Outstanding	3.81	2.55	2.54	2.18	2.17	1.7
Total Common Shares Outstanding	3.7	2.55	2.47	2.18	2.17	1.7
Working Capital	4.19	3.5	5.94	7.19	44.37	41.55
Book Value Per Share	2.58	3.48	4.56	4.80	22.23	34.95
Tangible Book Value	9.54	8.85	11.29	10.45	48.25	59.49
Tangible Book Value Per Share	2.58	3.48	4.56	4.80	22.23	34.95
Machinery	-	-	-	-	0.05	0.04
Leasehold Improvements	-	-	-	-	-	14.89

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q